FDA approves Aegerion's cholesterol drug with strongest warning

(Reuters) - Aegerion Pharmaceuticals Inc said the U.S. health regulator approved its drug as an alternative treatment for patients who have a genetic predisposition to high cholesterol. The drug, Juxtapid, would carry a boxed warning -- the strong...

Source: http://health.yahoo.net/news/s/nm/fda-approves-aegerion-s-cholesterol-drug-with-strongest-warning

as an example explained here as explained here resource